The Latest Digital Pathology Industry Statistics Explained
The global digital pathology market was valued at USD 600 million in 2019.
The statistic indicates that the global digital pathology market generated a revenue of USD 600 million in 2019. Digital pathology involves the use of digital tools to analyze and interpret pathological data, including images of tissue samples. The market value serves as a measure of the industry’s size and economic contribution. The specific amount signifies the total value of digital pathology products and services sold globally in that year, reflecting the demand for digital pathology solutions among healthcare providers, research institutions, and other stakeholders. This statistic provides insights into the growth and significance of digital pathology technology in modern healthcare practices and research efforts.
The digital pathology market is projected to reach USD 1,054 million by 2025.
The statistic “The digital pathology market is projected to reach USD 1,054 million by 2025” indicates the estimated value of the digital pathology market in terms of revenue by the year 2025. This projection suggests a significant growth in the market compared to its current value, reflecting a growing adoption of digital pathology technology in the healthcare industry. Factors driving this growth may include advancements in technology, increasing demand for efficient diagnostic tools, and the benefits of digital pathology such as improved accuracy, speed, and accessibility of pathology services. This projected market size serves as a valuable insight for industry stakeholders, investors, and policymakers to understand the potential opportunities and trends in the digital pathology market.
The digital pathology market in North America was worth USD 219 million in 2019.
The statistic that the digital pathology market in North America was worth USD 219 million in 2019 represents the total value of revenue generated by the digital pathology sector within North America during that year. This figure indicates the economic significance and growth potential of digital pathology technologies and services in the region, reflecting the increasing adoption of digital solutions in the healthcare industry. It serves as a key metric for understanding the market size, trends, and opportunities in the digital pathology sector, providing valuable insights for businesses, investors, and policymakers in the healthcare and technology fields.
The compound annual growth rate (CAGR) of the digital pathology market is estimated to be 11.8% from 2020 to 2027.
The compound annual growth rate (CAGR) of 11.8% in the digital pathology market from 2020 to 2027 indicates the average annual growth rate of the market over this period. This growth rate takes into account the compounding effect of year-over-year growth, providing a more accurate measure of the market’s expansion. An 11.8% CAGR suggests a steady, yet significant increase in market size, as businesses and healthcare providers continue to adopt digital pathology solutions. This growth rate can be indicative of technological advancements, increased adoption of digital systems for pathology diagnosis, and the overall growth potential of the digital pathology industry over the specified timeframe.
Rising prevalence of cancer is expected to drive the growth of the digital pathology market.
The statistic ‘Rising prevalence of cancer is expected to drive the growth of the digital pathology market’ signifies a potential relationship between the increasing incidence of cancer cases and the expansion of the digital pathology sector. As the number of cancer patients continues to rise globally, there is a growing demand for more efficient and advanced diagnostic tools and technologies to accurately diagnose and treat the disease. Digital pathology offers innovative solutions, such as digitizing slides for remote access and analysis, utilizing artificial intelligence algorithms for pathology image interpretation, and enabling teleconsultation among pathologists. As a result, the escalating need for improved cancer diagnostics and personalized treatment options is propelling the adoption of digital pathology systems, fostering market growth in response to the rising cancer prevalence.
Over 32% of the total market share was held by the disease diagnosis segment in 2019.
This statistic indicates that in 2019, the disease diagnosis segment accounted for more than one-third (32%) of the entire market share in the relevant industry. This suggests that the disease diagnosis segment held a significant portion of the market compared to other segments or competitors. It implies that the products or services related to disease diagnosis were in high demand or considered crucial by consumers or healthcare providers, resulting in a dominant position in the market share. Overall, this statistic highlights the importance and prevalence of disease diagnosis within the industry during the specified period.
The digital pathology market in Europe is expected to reach USD 358.3 million by 2027.
The statistic indicates that the digital pathology market in Europe is projected to grow significantly and reach a value of USD 358.3 million by the year 2027. This growth can be attributed to various factors such as advancements in technology, increasing adoption of digital pathology solutions by healthcare providers, and a rising demand for more efficient and accurate diagnostic tools. The expansion of the digital pathology market reflects a shift towards digitalization in the healthcare industry, offering opportunities for improved diagnosis, treatment planning, and data management. This statistic not only highlights the growing importance of digital pathology in Europe but also signals a trend towards greater integration of technology in healthcare services.
Hospitals are the largest end-user of digital pathology solutions as of 2020.
The statistic that hospitals are the largest end-user of digital pathology solutions as of 2020 indicates that hospitals are the primary facilities adopting and utilizing technology in the field of pathology. Digital pathology solutions refer to the use of digital imaging technology to analyze and interpret pathology samples such as tissue and cellular specimens. This trend highlights the increasing reliance on digital tools for diagnosing and managing diseases within healthcare settings, particularly in hospitals where pathology services are critical for accurate diagnosis and treatment planning. As hospitals embrace digital pathology solutions, it signifies a shift towards more efficient and advanced methods of visualizing and interpreting medical data, ultimately improving patient care and outcomes.
In 2018, Canada held a revenue of around USD 35 million in the digital pathology market.
The statistic indicates that in the year 2018, Canada generated approximately USD 35 million in revenue from the digital pathology market. This figure represents the total income received from sales and services related to digital pathology technology within Canada during that year. The revenue generated suggests a notable level of activity and investment in digital pathology within the country, reflecting the growing importance and adoption of digital pathology solutions in the healthcare sector. This statistic can be used to assess the market size and economic impact of digital pathology technology within Canada in 2018.
The academic and research centers segment in the digital pathology market is expected to grow at a CAGR of 14.6% from 2020 to 2027.
This statistic indicates that the academic and research centers segment within the digital pathology market is projected to experience a Compound Annual Growth Rate (CAGR) of 14.6% between the years 2020 and 2027. This growth rate suggests a strong and steady increase in demand for digital pathology solutions within academic and research settings over the specified time period. Factors contributing to this growth might include a rising emphasis on digitalization in diagnostic processes, advancements in imaging technology, and expanding research initiatives in fields such as oncology and neuroscience. The anticipated growth in this segment highlights the increasing adoption and integration of digital pathology technologies within academic and research institutions, positioning them as key drivers of market expansion in the coming years.
In 2019, scanners generated a revenue of USD 306 million in the global digital pathology market.
In 2019, the revenue generated by scanners in the global digital pathology market reached USD 306 million. This statistic indicates the significant economic value of scanners within the digital pathology industry, which involves the digitization and analysis of tissue samples for diagnostics, research, and education. The revenue figure suggests a thriving market demand for advanced imaging technology like scanners that play a crucial role in enhancing the efficiency, accuracy, and accessibility of pathology services. The substantial financial value associated with scanners highlights their importance in driving innovation and growth in the digital pathology sector.
The Asia-Pacific digital pathology market is forecasted to grow at a CAGR of 13.6% in the period 2020-2025.
This statistic indicates that the Asia-Pacific digital pathology market is projected to experience a compound annual growth rate (CAGR) of 13.6% between the years 2020 and 2025. This growth rate suggests a substantial increase in the adoption and utilization of digital pathology technologies and solutions across the Asia-Pacific region during this period. Factors contributing to this growth may include advancements in technology, increasing demand for efficient and accurate diagnostic solutions, improvements in healthcare infrastructure, and the rising prevalence of chronic diseases requiring pathology services. The forecasted CAGR of 13.6% highlights a significant market opportunity and signals a positive outlook for the digital pathology industry in the Asia-Pacific region over the next few years.
Telepathology is the most widely used technology in digital pathology as of 2019.
Based on available data as of 2019, the statistic indicates that telepathology is the primary and most commonly utilized technology within the field of digital pathology. This suggests that telepathology, which involves the remote interpretation of pathology images and providing consultations without the physical presence of a pathologist, has gained significant traction and adoption in the pathology sector. The widespread use of telepathology highlights its potential benefits in enabling remote collaboration, faster diagnoses, and improved accessibility to pathology expertise, ultimately contributing to advancements in healthcare delivery and patient care.
Over 37% of the digital pathology market was held by North America in 2020.
The statement “Over 37% of the digital pathology market was held by North America in 2020” implies that North America accounted for more than 37% of the total market share within the digital pathology industry during the year 2020. This statistic highlights the significant presence of North America in the global digital pathology market, indicating that the region played a dominant role in driving the overall market trends and developments within the digital pathology sector. The high market share held by North America suggests that the region has been a key player in driving innovation, research, and adoption of digital pathology technologies and solutions in 2020, showcasing its strong influence and leadership in this particular industry.
By 2027, it is predicted that over 60% of pathology laboratories will adopt digital pathology.
The statistic indicates a significant trend towards the adoption of digital pathology within pathology laboratories, with a projected adoption rate of over 60% by 2027. Digital pathology involves the digitization of traditional glass slides used in pathology, enabling the viewing, analysis, and sharing of images in a digital format. This shift towards digital pathology is likely driven by advancements in technology, such as whole slide imaging systems, deep learning algorithms for analysis, and the increasing need for remote access and collaboration in healthcare. The adoption of digital pathology is expected to bring benefits such as improved efficiency, accuracy, and accessibility of pathology services, potentially revolutionizing the field of pathology in the near future.
The pharmaceutical and biotechnology companies segment in the digital pathology market is expected to grow at a CAGR of 13.9% from 2020 to 2027.
This statistic indicates that the pharmaceutical and biotechnology companies segment within the digital pathology market is projected to experience a Compound Annual Growth Rate (CAGR) of 13.9% from 2020 to 2027. This implies that over the specified period, the revenue generated by pharmaceutical and biotechnology companies in the digital pathology market is anticipated to increase at an average annual rate of 13.9%. The growth rate suggests a strong market opportunity and showcases the expanding adoption of digital pathology solutions within these industries. This upward trend may be driven by factors such as the increasing demand for advanced diagnostic technologies, enhanced precision and efficiency in pathology workflows, and the growing focus on personalized medicine within the pharmaceutical and biotechnology sectors.
Over 60% of cases in hospitals and diagnostic labs benefited from digital pathology in 2019.
The statistic ‘Over 60% of cases in hospitals and diagnostic labs benefited from digital pathology in 2019’ indicates that a significant majority of medical cases handled in these healthcare settings were positively impacted by the implementation of digital pathology technologies during that year. Digital pathology involves the use of digital imaging tools to analyze and interpret patient samples, facilitating faster and more accurate diagnosis, treatment planning, and data management. The statistic suggests that the adoption of digital pathology not only improved the efficiency and quality of healthcare services but also likely contributed to better patient outcomes by enabling healthcare professionals to make more informed decisions.
The software segment is expected to witness the fastest growth with a CAGR of 12% between 2019 and 2027 in the digital pathology market.
This statistic indicates that the digital pathology market is projected to experience significant growth, with the software segment leading the way by exhibiting the fastest Compound Annual Growth Rate (CAGR) of 12% between 2019 and 2027. This suggests that the demand for digital pathology software solutions is expected to increase at a strong and steady pace over the forecast period, driven by factors such as technological advancements, rising adoption of digital pathology systems, and the need for efficient and automated tools for analyzing pathology images. The strong growth forecast for the software segment highlights its potential to be a key driver of market expansion and innovation in the digital pathology industry.
References
0. – https://www.www.marketsandmarkets.com
1. – https://www.www.gminsights.com
2. – https://www.www.globenewswire.com
3. – https://www.www.alliedmarketresearch.com
4. – https://www.www.datamintelligence.com
5. – https://www.www.emergenresearch.com
6. – https://www.www.futuremarketinsights.com
7. – https://www.www.polarismarketresearch.com
8. – https://www.www.grandviewresearch.com
9. – https://www.www.mordorintelligence.com
10. – https://www.www.fortunebusinessinsights.com
